TGFB1 and cancer: Some reports have shown that TGF-β and SMAD signaling enhances the DNA damage response to maintain genomic stability [121,122]; however, others have shown that CD44+/CD24- cancer cells with constitutively activated TGF-β signaling are defective in DNA repair, which makes their genomes less clonal following dsDNA breaks [123].